Structure | Chemical Name | CAS | MF |
|
armillaritin
|
135247-96-0
|
C23H28O7
|
|
armillarivin
|
135247-97-1
|
C23H28O5
|
|
yiyeliangwanoside II
|
135248-38-3
|
C37H56O10
|
|
2-chloro-2-fluoro-N-(2-(4-nitrophenyl)ethyl)acetamide
|
135248-51-0
|
C10H10ClFN2O3
|
|
Fmoc-L-Cysteine
|
135248-89-4
|
C18H17NO4S
|
|
1H-Pyrrole-3-carbonitrile, 5-(trifluoroacetyl)- (9CI)
|
135250-38-3
|
C7H3F3N2O
|
|
(E)-3-(6-bromo-1H-indol-3-yl)acrylic acid
|
135250-41-8
|
C11H8BrNO2
|
|
azidophenazocine
|
135250-44-1
|
C22H26N4O
|
|
D-LUCIFERIN, ETHYL ESTER
|
135251-85-3
|
C13H12N2O3S2
|
|
(E)-2-Hexadecenoic Acid Ethyl Ester
|
135251-95-5
|
C18H34O2
|
|
Remacemide
|
135252-01-6
|
|
|
(2,6-Diisopropyl-4-Phenoxy)Phenylthiourea
|
135252-10-7
|
C19H24N2OS
|
|
Urea, (1H-benzimidazol-2-ylmethyl)- (9CI)
|
135252-39-0
|
C9H10N4O
|
|
Dimethyl (ethoxycarbonyl)hydroxymethyl phosphonate
|
135253-58-6
|
C6H13O6P
|
|
crambescidin 816
|
135257-45-3
|
C45H80N6O7
|
|
DIDEMNAKETAL B
|
135257-48-6
|
C52H86O15
|
|
DIDEMNAKETAL A
|
135257-49-7
|
C44H72O14
|
|
1-(Dimethylamino)-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]-2-propanol hydrochloride
|
135261-74-4
|
C20H28ClNO3
|
|
3-Quinolinecarboxylicacid,1-amino-1,4-dihydro-4-oxo-(9CI)
|
135261-77-7
|
C10H8N2O3
|
|
NLE-ANTIFLAMMIN-2
|
135261-87-9
|
C44H73N13O16
|
|
NIPS HCL
|
135261-88-0
|
C32H33FN4O2S
|
|
Carbamic acid, (6-methyl-3-cyclohexen-1-yl)-, 1,1-dimethylethyl ester, trans-
|
135262-83-8
|
C12H21NO2
|
|
Carbamic acid, 3-cyclohexen-1-yl-, 1,1-dimethylethyl ester (9CI)
|
135262-85-0
|
C11H19NO2
|
|
(5-(nitro-2-furyl)-1,3,4-oxadiazol-2-ylthio)acethydrazide
|
135264-36-7
|
C8H7N5O5S
|
|
SULFONYL AMIDE, POLYMER-SUPPORTED
|
135266-23-8
|
C24H25NO2S
|
|
4-Nitrophenyl 2-(AcetylaMino)-2-deoxy-α-D-galactopyranoside 3,4,6-Triacetate
|
135266-95-4
|
C20H24N2O11
|
|
2-Cycloocten-1-amine,(S)-(9CI)
|
135268-94-9
|
C8H15N
|
|
4-TERT-BUTYL-CALIX[4]ARENE TETRA-N-PROPYL ETHER
|
135269-36-2
|
C56H80O4
|
|
D-MYO-INOSITOL 1,3,4,5-TETRAKIS-PHOSPHATE POTASSIUM SALT
|
135269-51-1
|
C6H15KO18P4
|
|
N(4)-(1(b),2(a),3(a)-trihydroxy-4(b)-1,2,3,4-tetrahydronaphthyl)-2'-deoxycytidine
|
135269-59-9
|
C19H23N3O7
|
|
(2S,3S)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol
|
135270-05-2
|
C12H13F2N3O2
|
|
1-(((2S,3R)-2-(2,4-difluorophenyl)-3-Methyloxiran-2-yl)Methyl)-1H-1,2,4-triazole
|
135270-07-4
|
C12H11F2N3O
|
|
4-[(2R)-2-(3,4,5,6-tetrahydro-2H-pyran-2-yloxy)-propionyl]morpholine
|
135270-08-5
|
C12H21NO4
|
|
135270-10-9
|
135270-10-9
|
C12H11F2N3O
|
|
135270-13-2
|
135270-13-2
|
C12H11F2N3O
|
|
(R)-2-Acetamido-3-(4-chlorophenyl)propanoic acid
|
135270-40-5
|
C11H12ClNO3
|
|
R-(-)-Salmeterol
|
135271-47-5
|
C25H37NO4
|
|
(S)-Salmeterol
|
135271-48-6
|
C25H37NO4
|
|
(R)-Salmeterol 1-hydroxy-2-naphthoic acid salt
|
135271-49-7
|
C36H45NO7
|
|
2-Naphthalenecarboxylic acid, 1-hydroxy-, compd. with (S)-4-hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol (1:1)
|
135271-50-0
|
C36H45NO7
|
|
8(R)-HHXTRE
|
135271-51-1
|
C16H26O3
|
|
2-(2,4-Difluorophenyl)-3-mercapto-1-(1H-1,2,4-triazol-1-yl)-2-butanol
|
135272-34-3
|
C12H13F2N3OS
|
|
yiyeliangwanoside I
|
135272-49-0
|
C57H88O25
|
|
Soyasaponin Bd
|
135272-91-2
|
C48H76O19
|
|
(FMOC-CYS-OH)2
|
135273-01-7
|
C36H32N2O8S2
|
|
1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium
|
135273-74-4
|
C8H13ClN2OS
|
|
TrimethylammoniummercaptododecaboratenaturalBabundance,Me3NH-BSH
|
135274-62-3
|
C4H13B12NS+
|
|
1-(4-FLUOROPHENYL)-3-(2-HYDROXYPHENYL)PROPANE-1,3-DIONE
|
135276-47-0
|
C15H11FO3
|
|
2-(PYRROLIDIN-1-YLMETHYL)BENZONITRILE
|
135277-07-5
|
C12H14N2
|
|
2-(piperidin-1-ylmethyl)benzonitrile
|
135277-08-6
|
C13H16N2
|
|
2-[(tert-butylaMino)carbonyl]thiophene-3-carboxylic acid
|
135278-56-7
|
C10H13NO3S
|
|
Propanoic acid, 2-[(ethoxyamino)carbonyl]hydrazide
|
135280-72-7
|
C6H13N3O3
|
|
3H-1,2,4-Triazol-3-one,5-ethyl-2,4-dihydro-4-(1-methylethyl)-(9CI)
|
135280-78-3
|
C7H13N3O
|
|
2-[[(4-Aminophenyl)sulfonyl]amino]-4-thiazoleacetic acid
|
135285-81-3
|
C11H11N3O4S2
|
|
hexanitrohexaazaisowurzitane
|
135285-90-4
|
C6H6N12O12
|
|
(S)-2-PHENYL-2-PHENYLAMINO-ETHANOL
|
135285-98-2
|
C14H15NO
|
|
2-PHENYL-2-PIPERIDIN-1-YL-ETHANOL
|
135286-01-0
|
C13H19NO
|
|
9-Oxa-4-thiabicyclo[6.1.0]nonane (9CI)
|
135286-42-9
|
C7H12OS
|
|
LAMOTRIGINE-2N-GLUCURONIDE
|
135288-68-5
|
C15H15Cl2N5O6
|
|
4-(4-DIPENTADECYLAMINOSTYRYL)-N-METHYLPYRIDINIUM IODIDE
|
135288-72-1
|
C44H75IN2
|
|
Pyrazinemethanamine, 3-amino-5-methoxy- (9CI)
|
135290-19-6
|
C6H10N4O
|
|
Acetonitrile, (3-fluorophenoxy)- (9CI)
|
135290-20-9
|
C8H6FNO
|
|
(2-methoxyethoxy)acetonitrile
|
135290-24-3
|
C5H9NO2
|
|
Pyrazinecarbonitrile, 3-amino-5-methoxy- (9CI)
|
135291-84-8
|
C6H6N4O
|
|
2,7-Naphthalenedisulfonic acid, 5-4-chloro-6-4-2-(sulfooxy)ethylsulfonylphenylamino-1,3,5-triazin-2-ylamino-4-hydroxy-3-(3-sulfophenyl)azo-, tetrasodium salt
|
135292-05-6
|
C27H23ClN7NaO16S5
|
|
2-Chloro-4-Methoxy-5-Methyl-pyriMidine
|
135292-35-2
|
C6H7ClN2O
|
|
5-aminoshikimate-3-phosphate
|
135292-59-0
|
C7H12NO7P
|
|
1-Cyclohexene-1-carboxylicacid,5-amino-3,4-dihydroxy-,methylester,[3R-
|
135292-63-6
|
C8H13NO4
|
|
2'-O-RHAMNOSYLICARISIDE II
|
135293-13-9
|
C33H40O14
|
|
2-Hexenoic acid, 5-hydroxy-, 1,1-dimethylethyl ester, (Z)-(+/-)-
|
135294-87-0
|
C10H18O3
|
|
3-(bromomethyl)fluoranthene
|
135294-98-3
|
C17H11Br
|
|
7-HYDROXYMETHYLFLUORANTHENE
|
135294-99-4
|
C17H12O
|
|
3-hydroxy-5,8,11,14-eicosatetraenoic acid
|
135295-02-2
|
|
|
9-(3-fluoro-2-phosphonylmethoxypropyl)adenine
|
135295-27-1
|
C9H13FN5O4P
|
|
Osmium(III) chloride trihydrate
|
135296-80-9
|
Cl3H6O3Os
|
|
4,5-Thiazoledicarboxylicacid,2-chloro-,diethylester(9CI)
|
135297-41-5
|
C9H10ClNO4S
|
|
1H-Pyrrole,1-ethenyl-2-(1-methylethyl)-(9CI)
|
135299-58-0
|
C9H13N
|
|
3H-1,2,4-Triazol-3-one,2,4-dihydro-4-(1-methylethyl)-5-propyl-(9CI)
|
135301-59-6
|
C8H15N3O
|
|
3H-1,2,4-Triazol-3-one,4-ethyl-2,4-dihydro-5-(1-methylethyl)-(9CI)
|
135301-61-0
|
C7H13N3O
|
|
3H-1,2,4-Triazol-3-one,2,4-dihydro-5-(1-methylethyl)-4-propyl-(9CI)
|
135301-62-1
|
C8H15N3O
|
|
3H-1,2,4-Triazol-3-one,2,4-dihydro-4,5-bis(1-methylethyl)-(9CI)
|
135301-63-2
|
C8H15N3O
|
|
3H-1,2,4-Triazol-3-one,2,4-dihydro-4-methoxy-5-(1-methylethyl)-(9CI)
|
135301-67-6
|
C6H11N3O2
|
|
3H-1,2,4-Triazol-3-one,4-cyclopropyl-2,4-dihydro-5-(1-methylethyl)-(9CI)
|
135301-71-2
|
C8H13N3O
|
|
3H-1,2,4-Triazol-3-one,4-amino-2,4-dihydro-5-methoxy-(9CI)
|
135301-94-9
|
C3H6N4O2
|
|
2,4-Dihydro-5-methoxy-4-methyl-3H-1,2,4-triazol-3-one
|
135302-13-5
|
C4H7N3O2
|
|
Butanoic acid, 2-[(methoxyamino)carbonyl]hydrazide
|
135302-15-7
|
C6H13N3O3
|
|
Propanoic acid, 2-methyl-, 2-[(methoxyamino)carbonyl]hydrazide
|
135302-16-8
|
C6H13N3O3
|
|
Propanoic acid, 2-methyl-, 2-[(cyclopropylamino)carbonyl]hydrazide
|
135302-20-4
|
C8H15N3O2
|
|
Propanoic acid, 2-[(cyclopropylamino)carbonyl]hydrazide
|
135302-21-5
|
C7H13N3O2
|
|
Butanoic acid, 2-[(2-propenylamino)carbonyl]hydrazide (9CI)
|
135302-26-0
|
C8H15N3O2
|
|
AFC
|
135304-07-3
|
C20H33NO3S
|
|
AC-CYS(FARNESYL)-OME
|
135304-08-4
|
C21H35NO3S
|
|
Furo(3,2-b)furan, D-glucitol deriv.
|
135304-12-0
|
C12H11FN2O7
|
|
Carbamic acid, (2-formyl-3-oxo-1-propenyl)-, ethyl ester (9CI)
|
135305-08-7
|
C7H9NO4
|
|
Carbamic acid, (2-formyl-3-oxo-1-propenyl)-, 1,1-dimethylethyl ester (9CI)
|
135305-09-8
|
C9H13NO4
|
|
3',5'-Difluoropropiophenone
|
135306-45-5
|
C9H8F2O
|
|
Caloxetic Acid
|
135306-78-4
|
C23H33N3O11
|
|
H-ASP-TYR-D-TRP-VAL-D-TRP-D-TRP-LYS-NH2
|
135306-85-3
|
C57H68N12O10
|
|
1H-[1,2,4]Triazolo[1,2-a]pyridazine,2-acetyl-1-ethoxy-2,3-dihydro-(9CI)
|
135307-01-6
|
C10H15N3O2
|
|
1H-[1,2,4]Triazolo[1,2-a]pyridazin-1-ol, 2-acetyl-2,3-dihydro- (9CI)
|
135307-02-7
|
C8H11N3O2
|